Cargando…

An Update on the Immunotherapy for Oropharyngeal Squamous Cell Carcinoma

Oropharyngeal squamous cell carcinoma (OPSCC) is an uncommon malignancy worldwide. Remarkably, the rising incidence of OPSCC has been observed in many developed countries over the past few decades. On top of tobacco smoking and alcohol consumption, human papillomavirus (HPV) infection has become a m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yaxuan, Lan, Yunyun, Zhang, Zhe, Xiao, Xue, Huang, Tingting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965058/ https://www.ncbi.nlm.nih.gov/pubmed/35372036 http://dx.doi.org/10.3389/fonc.2022.800315

Ejemplares similares

The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma
por: Welters, Marij J. P., et al.
Publicado: (2020)

Editorial: Considerations in the surgical management of HPV-positive oropharyngeal squamous cell carcinoma
por: Mallen-St Clair, Jon, et al.
Publicado: (2023)

Merkel Cell Carcinoma: An Update and Immunotherapy
por: Uchi, Hiroshi
Publicado: (2018)

Oral health in HPV-positive and HPV-negative patients with oropharyngeal squamous cell carcinoma
por: Kanzow, Philipp, et al.
Publicado: (2023)

Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma
por: Boutros, Andrea, et al.
Publicado: (2021)

An Occult HPV-Driven Oropharyngeal Squamous Cell Carcinoma Discovered Through a Saliva Test
por: Tang, Kai Dun, et al.
Publicado: (2020)

Flap Reconstruction of the Oropharyngeal Defect After Tumor Resection via Combined Transcervical and Transoral Approach in Patients With HPV-Positive and -Negative Oropharyngeal Squamous Cell Carcinoma
por: Chen, Jiaming, et al.
Publicado: (2022)

Macrophages expressing TREM-1 are involved in the progression of HPV16-related oropharyngeal squamous cell carcinoma
por: Azzimonti, Barbara, et al.
Publicado: (2021)

Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and Perspectives
por: Alberti, Andrea, et al.
Publicado: (2022)

New Concepts for Translational Head and Neck Oncology: Lessons from HPV-Related Oropharyngeal Squamous Cell Carcinomas
por: Kostareli, Efterpi, et al.
Publicado: (2012)

Prognostic Impact of AJCC/UICC 8th Edition New Staging Rules in Oropharyngeal Squamous Cell Carcinoma
por: Würdemann, Nora, et al.
Publicado: (2017)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

Radiomic Features Associated With HPV Status on Pretreatment Computed Tomography in Oropharyngeal Squamous Cell Carcinoma Inform Clinical Prognosis
por: Song, Bolin, et al.
Publicado: (2021)

Prognostic Significance of PD-L1 Expression In Patients With Primary Oropharyngeal Squamous Cell Carcinoma: A Meta-Analysis
por: Polesel, Jerry, et al.
Publicado: (2021)

Immunotherapy to Avoid Orbital Exenteration in Patients With Cutaneous Squamous Cell Carcinoma
por: McLean, Luke S., et al.
Publicado: (2022)

Biomarkers for Immunotherapy of Oral Squamous Cell Carcinoma: Current Status and Challenges
por: Almangush, Alhadi, et al.
Publicado: (2021)

Case report: The power of immunotherapy in advanced cutaneous squamous cell carcinoma
por: Brockwell, Maximilian, et al.
Publicado: (2023)

The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy
por: Damasio, Marcos Paulo S., et al.
Publicado: (2022)

Prognostic prediction models for oropharyngeal squamous cell carcinoma (OPSCC): a protocol for systematic review, critical appraisal and meta-analysis
por: Lu, Zhen, et al.
Publicado: (2023)

Long-read sequencing of oropharyngeal squamous cell carcinoma tumors reveal diverse patterns of high-risk Human Papillomavirus integration
por: Gauthier, Marc-Andre, et al.
Publicado: (2023)

Editorial: News and update in transoral robotic surgery in oropharyngeal, hypopharyngeal, and laryngeal cancers
por: Mat Lazim, Norhafiza, et al.
Publicado: (2023)

METTL3 Is Associated With the Malignancy of Esophageal Squamous Cell Carcinoma and Serves as a Potential Immunotherapy Biomarker
por: Zhou, Yubin, et al.
Publicado: (2022)

Omitting Elective Irradiation of the Contralateral Retropharyngeal Nodes in Oropharyngeal Squamous Cell Carcinoma Treated with Intensity-modulated Radiotherapy
por: Nagatsuka, Moeko, et al.
Publicado: (2019)

Prediction of survival in oropharyngeal squamous cell carcinoma using machine learning algorithms: A study based on the surveillance, epidemiology, and end results database
por: Kim, Su Il, et al.
Publicado: (2022)

Neoadjuvant Immunotherapy of Oral Squamous Cell Carcinoma: Case Report and Assessment of Histological Response
por: Olmos, Manuel, et al.
Publicado: (2021)

Surgical clinical trials for HPV-positive oropharyngeal carcinoma
por: Lin, Chen, et al.
Publicado: (2022)

Perioperative Mortality Risk in Patients Undergoing Transoral Robotic Surgery for T1-T2 Oropharyngeal Squamous Cell Carcinoma: A National Cancer Database Study
por: Davies, Joel C., et al.
Publicado: (2022)

Prognostic Value of Tumor-Infiltrating Lymphocytes Differs Depending on Lymphocyte Subsets in Esophageal Squamous Cell Carcinoma: An Updated Meta-Analysis
por: Hao, Jiatao, et al.
Publicado: (2020)

Comprehensive Analysis of m(6)A Regulators Characterized by the Immune Cell Infiltration in Head and Neck Squamous Cell Carcinoma to Aid Immunotherapy and Chemotherapy
por: Yang, Zhiqiang, et al.
Publicado: (2021)

Positron Emission Tomography-Computed Tomography Parameters Predict Efficacy of Immunotherapy in Head and Neck Squamous Cell Carcinomas
por: Zhang, Songtao, et al.
Publicado: (2021)

Lipid Droplet-Related PLIN2 in CD68(+) Tumor-Associated Macrophage of Oral Squamous Cell Carcinoma: Implications for Cancer Prognosis and Immunotherapy
por: He, Yijia, et al.
Publicado: (2022)

Cuproptosis-related lncRNA SNHG16 as a biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma
por: Han, Baoai, et al.
Publicado: (2023)

The prognosis value of CONUT and SIS score for recurrent or metastatic esophageal squamous cell carcinoma patients treated with second-line immunotherapy
por: Zhao, Xiao-Han, et al.
Publicado: (2023)

Correlation Between TCF7(+) T Cells and Prognosis of Patients With Oral Squamous Cell Carcinoma
por: Rong, Haixu, et al.
Publicado: (2022)

Long Noncoding RNAs in the Metastasis of Oral Squamous Cell Carcinoma
por: Xu, Yuming, et al.
Publicado: (2021)

TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma
por: Zeng, Yun-Zhu, et al.
Publicado: (2021)

Significance of Extranodal Extension in Surgically Treated HPV-Positive Oropharyngeal Carcinomas
por: Beltz, Anna, et al.
Publicado: (2020)

Immunotherapy Combined With Chemotherapy for Postoperative Recurrent Penile Squamous Cell Carcinoma: A Case Report and Literature Review
por: Li, Na, et al.
Publicado: (2022)

Evolving Treatment Paradigms for Oropharyngeal Squamous Cell Carcinoma
por: Cleary, Ryan K., et al.
Publicado: (2016)

Histopathologic risk factors in oral and oropharyngeal squamous cell carcinoma variants: An update with special reference to HPV-related carcinomas
por: El-Mofty, Samir K.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h9cddhhn5stv952fg40dtk3jp5